Article Details

Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting ...

Retrieved on: 2020-01-26 14:56:15

Tags for this article:

Click the tags to see associated articles and topics

Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting .... View article details on hiswai:

Excerpt

<div><b>Atlas Venture</b> ("Atlas") and Arix Bioscience plc ("Arix", LSE: ARIX) who co-founded and seeded the company, also participated in the Series A. Quench ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up